News & Analysis on Clinical Trial Services & Contract Research And Development
Altasciences is set to acquire SNBL in a deal that looks to bridge the gap between preclinical and proof of concept studies – and provide an average of 25% time savings, says CEO.
An alliance between Kinetiq and Halley Consulting group aims to provide new services to the companies’ clients, from compensation analysis to technology compliance solutions.
Compass Pathways has received approval from the US FDA for a clinical trial using psilocybin, the active ingredient in ‘magic mushrooms.’
Alpha Genesis is exploring blockchain technology applications in its primate research activities – the use of which aims to boost transparency and traceability across several areas of the business.
The US FDA has vetoed Allergan’s ulipristal acetate candidate, designed for the treatment of abnormal uterine bleeding in women with uterine fibroids.
The DEA proposed an opioid reduction plan decreasing aggregate manufacturing quotas by 10%.
AstraZeneca has pushed back the expected completion date of its new Cambridge, UK headquarters to 2020, after changing contractors.
CRF Health has expanded its electronic consent platform to provide sponsors and CROs with a new self-service capability.
Evotec and Novo Nordisk have formed an alliance to further develop small molecule therapies to treat patients suffering from diabetes and obesity.